Hepatocyte Growth Factor (HGF)-Konzentrationen im Patientenserum sind nach partieller Hepatektomie mit dem Ausmaß an Parenchymverlust und mit postoperativ peripher mobilisierten CD34+ und CD133+ Stammzellen positiv korreliert

Hepatic Growth Factor (HGF)-concentrations in patients serum subsequent to partial hepatectomy are positively correlated with extend of parenchymal loss and post operative peripherally mobilised CD34+ and CD133+ stem cells

  • Conference paper
Chirurgisches Forum und DGAV Forum 2010

Abstract

In this study we investigated paracrine factors like HGF, insulin like growth factor 1 (IGF-1) stroma derived factor 1 (SDF-1) and stem cell factor (SCF) for correlation with peripheral progenitor mobilisation in the early course of hepatic resection using FACS-analyses in 30 patients and the extend of partial hepatectomy. CT-scan volumetry pre-operatively and 24 h following resection was utilized to determine the exact extend of liver volume loss. Serum growth fators and chemokine levels were compared among 20 patients with resection volume of less than 20 % (group A) of the pre-operative total liver volume – tumor volume (TLV) and 10 patients with a resection extend of 30 to 65 % (group B). In addition, peripheral CD133+ and CD34+ progenitor cells in peripheral blood were contrasted between the two groups up to post OP day (POD) 21. Early subsequent to the end of resection HGF (0, 6 and 24 h), SDF-1 (0, 3 and 6 h) and IGF-1 (3 h) were significantly increased in comparison to group A. We revealed a significant elevation from day 2 following liver surgery for CD133+ cells which was only seen for group B individuals and which was significantly superior to group A patients (p = 0.005). CD34+ cells demonstrated similar kinetics and differences among groups, however to a lesser extend. Only HGF directly correlated with mobilised mobilised CD34+ and CD133+ peripheral cells early after resection, independent of the extend of hepatectomy. These data suggest HGF to play a role in mobilisation of CD133+ and CD34+ cells respectively in regeneration processes subsequent to larger extend of loss of hepatic tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Fujii H, Hirose T, Yasuchika SOeK, Azuma H, Fujikawa T, Nagao M, Yamaoka Y (2002) Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 36: 653–659

    Article  CAS  PubMed  Google Scholar 

  2. Schulte am Esch J 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschlader M, Stoecklein NH, Tustas RY, Eisenberger CF, Peiper M, Haussinger D, Hosch SB (2005) Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23: 463–470

    Article  Google Scholar 

  3. Fürst G, Schulte am Esch J, Poll L, Hosch SB, Klein M, Godehardt E, Fritz B, Krieg A, Wecker B, Stoldt V, Stockschläder M, Mödder U, Knoefel WT (2007) Portal Vein Embolization and Application of Autologous CD133+ Bone Marrow Stem Cells to Support Liver Regeneration – Initial Experience. Radiology 243:171–179

    Article  PubMed  Google Scholar 

  4. Hegab AE, Kubo H, Yamaya M, Asada M, He M, Fu**o N, Mizuno S, Nakamura T (2008) Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol Ther 16:1417–26

    Article  CAS  PubMed  Google Scholar 

  5. Yang ZJ, Xu SL, Chen B, Zhang SL, Zhang YL, Wei W, Ma DC, Wang LS, Zhu TB, Li CJ, Wang H, Cao KJ, Gao W, Huang J, Ma WZ, Wu ZZ (2009) Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease. Clin Exp Pharmacol Physiol 36: 790–796

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schulte am Esch, J. et al. (2010). Hepatocyte Growth Factor (HGF)-Konzentrationen im Patientenserum sind nach partieller Hepatektomie mit dem Ausmaß an Parenchymverlust und mit postoperativ peripher mobilisierten CD34+ und CD133+ Stammzellen positiv korreliert. In: Gradinger, R., Menger, M., Meyer, HJ. (eds) Chirurgisches Forum und DGAV Forum 2010. Deutsche Gesellschaft für Chirurgie, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12192-0_56

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-12192-0_56

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-12191-3

  • Online ISBN: 978-3-642-12192-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Navigation